ENDOCRINE 润色咨询

ENDOCRINE

出版年份：1994 年文章数：3008 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：9.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2024-03-14 1234456789 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：在投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2024-03-06 1234456789 来自江苏省

    投稿命中率:25.0
    经验分享：在投

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2021-03-16 ms1000001155806208

    求该期刊的参考文献格式，谢谢！

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2024-01-26 水逆退散～ 来自广西

    偏重的研究方向：甲状腺
    经验分享：2024.1.25 editor appointed

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2023-09-03 ms3000000565671099 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：内分泌
    经验分享：感觉主编权力挺大的，人也很好，不刁钻

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2021-08-24 张晗玉

    我现在已经投稿了快60天，一直显示Under Review，老天啊

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2009-12-27 endocrine

    这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。

    Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4.

    Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25.

    Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44.
    我们总结下来，用基础研究的方法做临床，就基本没问题。

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2021-03-15 136****8751

    请教下各位大牛，这个杂志接受case report吗

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2022-10-07 ms1000000562543696

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺<br>经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省)]
    2023-03-13 ms7000001469871773 来自山东省

    虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～

    2

    展开2条回复
共153条页码: 2/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分